Skip navigation
Agenda

Innovative Pharmacy and Distribution Models Driven by Market Dynamics, Product Type, Site of Care and Reimbursement

December 3-5, 2019
  • Philadelphia, PA

Agenda

Want more agenda details? Download the brochure.

DAY ONE TUESDAY, DECEMBER 3, 2019

1:00

Conference Registration

2:00

CHOOSE BETWEEN TWO SUMMITS (I-II)

I. New Product Launch Planning

MODERATOR:

Marc Duey
CEO and President
ProMetrics LLC

PANELISTS:

Diana Dai
Executive Director,
US Pipeline and Launch Management
Sandoz

Sasha Zbitnoff
Associate Director,
Commercial Project Management
Alkermes

Paul Chen
Senior Director,
Trade and Specialty Pharmacy
Reata Pharmaceuticals, Inc.

II. Mitigate Compliance Risk in Manufacturer and Specialty Pharmacy Contracts

Shannon Wiley
Attorney
Bass Berry & Sims PLC

3:30

Networking and Refreshment Break

4:00

CHOOSE BETWEEN TWO SUMMITS (III-IV)

III. Digital and Blockchain Technology Adoption and Implementation

Speaker TBA

IV. Retail and Point-of-Sale Contracting

Jonathan Ogurchak, PharmD, CSP
Adjunct Professor, Master of Science in Pharmacy Business Administration
University of Pittsburgh

5:30

Close of Day One

Join Us... 15TH ANNIVERSARY CELEBRATION immediately following the summits on day one

DAY TWO WEDNESDAY, DECEMBER 4, 2019

7:30

Continental Breakfast Hosted by: Shields Health Solutions logo

8:30

Chairperson’s Welcome and Opening Remarks

Roxanne Schwans
Head of Market Access
Actelion Pharmaceuticals US, Inc. Division of Johnson & Johnson

8:45

HIGHLY-ACCLAIMED OPENING KEYNOTE Drug Channels Update — Things to Watch in 2020

Adam J. Fein, PhD
CEO
Drug Channels Institute

9:30

WALL STREET INSIGHTS Examine Revolutionary Deals, Market Dynamics and e-Commerce Players Impacting the Life Sciences Sector

MODERATOR:

Adam J. Fein, PhD
CEO
Drug Channels Institute

PANELISTS:

Bob Jones
Managing Director
Goldman Sachs

George Hill
Managing Director, Equity Research Analyst
Deutsche Bank Securities

Eric Coldwell
Managing Director, Senior Equity Research Analyst
Robert W. Baird & Co.

10:15

Networking and Refreshment Break

10:45

STATE OF PLAY Trends in Logistics, Distribution and Pharmacy for Orphan, Rare, Cell, Gene and Regenerative Therapies

I. 3PL Trends

II. Distribution Snapshot

III. Pharmacy Models

Sean Duffy
Principal Consultant
Blue Fin Group

11:30

Specialty Pharmacy Spotlight —
Deep Dive on Economics, Viability and Innovation

Rich Gourash
Vice President, Specialty Outcomes
Therigy

12:15

Networking Luncheon

1:15

Benefit Design and Network Management — Zero-In on Channel Strategies for Specialty Pharmacy Benefit and Specialty Medical Benefit

Gerard Rivera, PharmD
Chief Executive Officer
Pacific Pharmacy Group

Paul Maurer
Senior Consultant
Protean LLC

2:00

Critical Considerations for Optimizing Access to Rare and Orphan Therapies

Matt Seibt
Chief Commercial Officer
Acer Therapeutics Inc.

2:30

Networking and Refreshment Break

3:00

MEETING OF THE MANUFACTURER MINDS Network Blueprint for Trade and Channel — Strategic and Tactical Approaches Based on Site of Care, Product Type and Reimbursement

PANELISTS:

J’Aime Conrod, MSPH
Head of Specialty Markets, Market Access and Pricing
UCB, Inc.

Mike Steelman
Vice President, Market Access
TherapueticsMD

Roxanne Schwans
Head of Market Access
Actelion Pharmaceuticals US, Inc. Division of Johnson & Johnson

3:45

CASE STUDY Driving Improved Health and Economic Outcomes by Incorporating IDN-SPs in Manufacturer Network Design and Strategy

Stacy Walton, RN, BSN
Vice President, Trade Relations
Shields Health Solutions

4:15

Leverage Artificial Intelligence (AI) to Drive Specialty Channel Insights

Joshua Halpern
Co-Founder and Executive Vice President, Product and Strategy
IntegriChain

4:45

Brief Transition Break

5:00

CHOOSE FROM THREE WORKSHOPS (A-C)

A. Industry-Only* Trade Director’s Executive Exchange

FACILITATOR:

John Campo
Vice President, Commercial Channels
Boston Scientific

*CBI reserves the right to qualify participants for this session.

B. Forward-Thinking Strategies for
Specialty Generics and Biosimilars

Richard Williams, RPh
Senior Vice President, Pharmaceutical Innovation and Insights
CSI Specialty Group

C. 340B — Best Practices to
Improve Compliance and Manage Drug Diversion

Tess Morgan
Senior Manager, Product Diversion and Program Integrity
Pfizer Inc

5:45

Close of Day Two

Networking, Wine and
Cheese Reception
immediately following the close of day two

DAY THREE THURSDAY, DECEMBER 5, 2019

7:00

Women’s Leadership Breakfast Forum

This high-touch networking and learning course, tailored to women executives within the life sciences community, illustrates how women are climbing the leadership ladder and redefining career paths and empowerment. Hear compelling stories of personal career success, reflect on professional development opportunities, discover flashpoint moments and ways to inspire and elevate teams. Attendees discover meaningful mentorships and insights into optimal job placement and professional pathways.

7:15

Continental Breakfast

7:50

Chairperson’s Recap

Roxanne Schwans
Head of Market Access
Actelion Pharmaceuticals US, Inc. Division of Johnson & Johnson

LUMINARY SHOWCASE Stay on the Pulse of Industry Innovations and Market Disruptors

8:00

Fireside Chat — Candid Conversation with an Industry Pioneer

William Roth
Founding Partner
Blue Fin Group

8:45

PARTNERSHIP PAVILION Supply Chain Stakeholders Sound Off — Innovative Models Being Leveraged to Drive Product Pull Through and Patient Access

CONVERSATION CONTRIBUTORS:

Jim Van Lieshout, MBA
Senior Director, Industry Relations and Contracting
Navitus Health Solutions

Ameet Wattamwars, Pharm. D.
Specialty Pharmacy Program Director
NYU Langone Health System

9:30

How the New Wave of Algorithmic Care Will Disrupt Your Business

Zen Chu
Investor, PillPack;
Senior Lecturer in Healthcare Innovation,
MIT Sloan School of Management and Harvard-MIT Health Sciences & Technology

10:00

HHS KEYNOTE Healthcare Policy Address —
Current State of Regulatory Reform Driving Innovation and Access

Eric D. Hargan
Deputy Secretary
Department of Health and Human Services (HHS)

10:30

Networking and Refreshment Break

11:00

CHOOSE FROM THREE TAILORED TRACKS (1-3)

1. Specialty Channel Network Design and Contracting

11:00

Creative Contracts —
Cutting-Edge Frameworks Tailored to the Needs of the Market

MODERATOR:

Donovan Quill
President & CEO
Optime Care Inc.

PANELISTS:

John Campo
Vice President, Commercial Channels
Boston Scientific

11:40

Navigate Narrow Networks — Ensuring Patients Don’t Hit Roadblocks

Bob Raffo
President and CEO
FirstView

12:20

Networking Luncheon

1:20

Assessment of Channel Partners and Determining Who Should Do What —
3PL? Distributor? Pharmacy?

Mark Polidoro
Director, Consulting Services
ValueCentric

2. Market Access, Patient Support and Hub Services Optimization

11:00

Key Considerations for Market Access Compliance

Jennifer Chillas
Senior Corporate Counsel, Law Department
Bristol-Myers Squibb

Michael Diaco
Assistant General Counsel
Pfizer

11:40

Striking the Right Balance —
A Look at the Level of Integration between Hub and Pharmacy

MODERATOR:

Snehal Patel
Vice President, Pharmacy and Access Solutions
Asembia

PANELISTS:

Allison Bridges
Director, Access and Trade
kaléo

Paul Chen
Senior Director, Trade and Specialty Pharmacy
Reata Pharmaceuticals, Inc.

12:20

Networking Luncheon

1:20

Access and Affordability —
Zero-In on Coupons, Copays and Accumulator Programs

Gerard Rivera, PharmD
Chief Executive Officer
Pacific Pharmacy Group

3. Next-Gen Specialty Product Data Strategies

11:00

Data Standardization Across 3PL, Distribution and Pharmacy

Speaker TBA

11:40

Accomplish an Integrated Patient Journey Driven by Data

Marc Duey
CEO and President
ProMetrics LLC

12:20

Networking Luncheon

1:20

Optimize Commercial Operations by Aligning Brand, Market Access, Field Sales, Pharmacy Distribution and Patient Services

Speaker TBA

RECONVENE IN BALLROOM FOR CLOSING GENERAL SESSION

2:00

EXCLUSIVE BENCHMARKING REPORT REVEAL Industry Intelligence on the State of the Bio/Pharma Trade and
Channel Landscape

Benefit from a comprehensive wrap-up of benchmarking results representing the collective intelligence of the channel community from a sampling of companies (brand/generic, large/small and private/public). Content of the survey covers leading strategies and critical areas of focus.

2:45

Close of Conference

Agenda

Want more agenda details? Download the brochure.

Want more agenda details? Download the brochure.

DAY ONE TUESDAY, DECEMBER 3, 2019

1:00

Conference Registration

2:00

CHOOSE BETWEEN TWO SUMMITS (I-II)

I. New Product Launch Planning

MODERATOR:

Marc Duey
CEO and President
ProMetrics LLC

PANELISTS:

Diana Dai
Executive Director,
US Pipeline and Launch Management
Sandoz

Sasha Zbitnoff
Associate Director,
Commercial Project Management
Alkermes

Paul Chen
Senior Director,
Trade and Specialty Pharmacy
Reata Pharmaceuticals, Inc.

II. Mitigate Compliance Risk in Manufacturer and Specialty Pharmacy Contracts

Shannon Wiley
Attorney
Bass Berry & Sims PLC

3:30

Networking and Refreshment Break

4:00

CHOOSE BETWEEN TWO SUMMITS (III-IV)

III. Digital and Blockchain Technology Adoption and Implementation

Speaker TBA

IV. Retail and Point-of-Sale Contracting

Jonathan Ogurchak, PharmD, CSP
Adjunct Professor, Master of Science in Pharmacy Business Administration
University of Pittsburgh

5:30

Close of Day One

Join Us... 15TH ANNIVERSARY CELEBRATION immediately following the summits on day one

DAY TWO WEDNESDAY, DECEMBER 4, 2019

7:30

Continental Breakfast Hosted by: Shields Health Solutions logo

8:30

Chairperson’s Welcome and Opening Remarks

Roxanne Schwans
Head of Market Access
Actelion Pharmaceuticals US, Inc. Division of Johnson & Johnson

8:45

HIGHLY-ACCLAIMED OPENING KEYNOTE Drug Channels Update — Things to Watch in 2020

Adam J. Fein, PhD
CEO
Drug Channels Institute

9:30

WALL STREET INSIGHTS Examine Revolutionary Deals, Market Dynamics and e-Commerce Players Impacting the Life Sciences Sector

MODERATOR:

Adam J. Fein, PhD
CEO
Drug Channels Institute

PANELISTS:

Bob Jones
Managing Director
Goldman Sachs

George Hill
Managing Director, Equity Research Analyst
Deutsche Bank Securities

Eric Coldwell
Managing Director, Senior Equity Research Analyst
Robert W. Baird & Co.

10:15

Networking and Refreshment Break

10:45

STATE OF PLAY Trends in Logistics, Distribution and Pharmacy for Orphan, Rare, Cell, Gene and Regenerative Therapies

I. 3PL Trends

II. Distribution Snapshot

III. Pharmacy Models

Sean Duffy
Principal Consultant
Blue Fin Group

11:30

Specialty Pharmacy Spotlight —
Deep Dive on Economics, Viability and Innovation

Rich Gourash
Vice President, Specialty Outcomes
Therigy

12:15

Networking Luncheon

1:15

Benefit Design and Network Management — Zero-In on Channel Strategies for Specialty Pharmacy Benefit and Specialty Medical Benefit

Gerard Rivera, PharmD
Chief Executive Officer
Pacific Pharmacy Group

Paul Maurer
Senior Consultant
Protean LLC

2:00

Critical Considerations for Optimizing Access to Rare and Orphan Therapies

Matt Seibt
Chief Commercial Officer
Acer Therapeutics Inc.

2:30

Networking and Refreshment Break

3:00

MEETING OF THE MANUFACTURER MINDS Network Blueprint for Trade and Channel — Strategic and Tactical Approaches Based on Site of Care, Product Type and Reimbursement

PANELISTS:

J’Aime Conrod, MSPH
Head of Specialty Markets, Market Access and Pricing
UCB, Inc.

Mike Steelman
Vice President, Market Access
TherapueticsMD

Roxanne Schwans
Head of Market Access
Actelion Pharmaceuticals US, Inc. Division of Johnson & Johnson

3:45

CASE STUDY Driving Improved Health and Economic Outcomes by Incorporating IDN-SPs in Manufacturer Network Design and Strategy

Stacy Walton, RN, BSN
Vice President, Trade Relations
Shields Health Solutions

4:15

Leverage Artificial Intelligence (AI) to Drive Specialty Channel Insights

Joshua Halpern
Co-Founder and Executive Vice President, Product and Strategy
IntegriChain

4:45

Brief Transition Break

5:00

CHOOSE FROM THREE WORKSHOPS (A-C)

A. Industry-Only* Trade Director’s Executive Exchange

FACILITATOR:

John Campo
Vice President, Commercial Channels
Boston Scientific

*CBI reserves the right to qualify participants for this session.

B. Forward-Thinking Strategies for
Specialty Generics and Biosimilars

Richard Williams, RPh
Senior Vice President, Pharmaceutical Innovation and Insights
CSI Specialty Group

C. 340B — Best Practices to
Improve Compliance and Manage Drug Diversion

Tess Morgan
Senior Manager, Product Diversion and Program Integrity
Pfizer Inc

5:45

Close of Day Two

Networking, Wine and
Cheese Reception
immediately following the close of day two

DAY THREE THURSDAY, DECEMBER 5, 2019

7:00

Women’s Leadership Breakfast Forum

This high-touch networking and learning course, tailored to women executives within the life sciences community, illustrates how women are climbing the leadership ladder and redefining career paths and empowerment. Hear compelling stories of personal career success, reflect on professional development opportunities, discover flashpoint moments and ways to inspire and elevate teams. Attendees discover meaningful mentorships and insights into optimal job placement and professional pathways.

7:15

Continental Breakfast

7:50

Chairperson’s Recap

Roxanne Schwans
Head of Market Access
Actelion Pharmaceuticals US, Inc. Division of Johnson & Johnson

LUMINARY SHOWCASE Stay on the Pulse of Industry Innovations and Market Disruptors

8:00

Fireside Chat — Candid Conversation with an Industry Pioneer

William Roth
Founding Partner
Blue Fin Group

8:45

PARTNERSHIP PAVILION Supply Chain Stakeholders Sound Off — Innovative Models Being Leveraged to Drive Product Pull Through and Patient Access

CONVERSATION CONTRIBUTORS:

Jim Van Lieshout, MBA
Senior Director, Industry Relations and Contracting
Navitus Health Solutions

Ameet Wattamwars, Pharm. D.
Specialty Pharmacy Program Director
NYU Langone Health System

9:30

How the New Wave of Algorithmic Care Will Disrupt Your Business

Zen Chu
Investor, PillPack;
Senior Lecturer in Healthcare Innovation,
MIT Sloan School of Management and Harvard-MIT Health Sciences & Technology

10:00

HHS KEYNOTE Healthcare Policy Address —
Current State of Regulatory Reform Driving Innovation and Access

Eric D. Hargan
Deputy Secretary
Department of Health and Human Services (HHS)

10:30

Networking and Refreshment Break

11:00

CHOOSE FROM THREE TAILORED TRACKS (1-3)

1. Specialty Channel Network Design and Contracting

11:00

Creative Contracts —
Cutting-Edge Frameworks Tailored to the Needs of the Market

MODERATOR:

Donovan Quill
President & CEO
Optime Care Inc.

PANELISTS:

John Campo
Vice President, Commercial Channels
Boston Scientific

11:40

Navigate Narrow Networks — Ensuring Patients Don’t Hit Roadblocks

Bob Raffo
President and CEO
FirstView

12:20

Networking Luncheon

1:20

Assessment of Channel Partners and Determining Who Should Do What —
3PL? Distributor? Pharmacy?

Mark Polidoro
Director, Consulting Services
ValueCentric

2. Market Access, Patient Support and Hub Services Optimization

11:00

Key Considerations for Market Access Compliance

Jennifer Chillas
Senior Corporate Counsel, Law Department
Bristol-Myers Squibb

Michael Diaco
Assistant General Counsel
Pfizer

11:40

Striking the Right Balance —
A Look at the Level of Integration between Hub and Pharmacy

MODERATOR:

Snehal Patel
Vice President, Pharmacy and Access Solutions
Asembia

PANELISTS:

Allison Bridges
Director, Access and Trade
kaléo

Paul Chen
Senior Director, Trade and Specialty Pharmacy
Reata Pharmaceuticals, Inc.

12:20

Networking Luncheon

1:20

Access and Affordability —
Zero-In on Coupons, Copays and Accumulator Programs

Gerard Rivera, PharmD
Chief Executive Officer
Pacific Pharmacy Group

3. Next-Gen Specialty Product Data Strategies

11:00

Data Standardization Across 3PL, Distribution and Pharmacy

Speaker TBA

11:40

Accomplish an Integrated Patient Journey Driven by Data

Marc Duey
CEO and President
ProMetrics LLC

12:20

Networking Luncheon

1:20

Optimize Commercial Operations by Aligning Brand, Market Access, Field Sales, Pharmacy Distribution and Patient Services

Speaker TBA

RECONVENE IN BALLROOM FOR CLOSING GENERAL SESSION

2:00

EXCLUSIVE BENCHMARKING REPORT REVEAL Industry Intelligence on the State of the Bio/Pharma Trade and
Channel Landscape

Benefit from a comprehensive wrap-up of benchmarking results representing the collective intelligence of the channel community from a sampling of companies (brand/generic, large/small and private/public). Content of the survey covers leading strategies and critical areas of focus.

2:45

Close of Conference